爱普股份(603020.SH)：与挪亚圣诺欧洲签订《股权收购意向协议》

Core Viewpoint - The company aims to enhance its strategic layout and achieve high-quality development through the acquisition of 100% equity in Noah San诺 (Taicang) Biotechnology Co., Ltd. [1] Group 1: Acquisition Details - On February 4, 2026, the company signed a share acquisition intention agreement with Noah San诺 Europe [1] - The company plans to acquire 80% of the target company's equity in the first transaction, with the remaining equity to be acquired after the performance commitment period [1] - The transaction price will be determined based on due diligence, auditing, and evaluation results, and will be negotiated between both parties [1]